arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Aurinia Pharmaceuticals Inc.

AUPH

$15.84 ▼ -0.29 (-1.80%) at close

10 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

Aurinia Pharmaceuticals Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $2.1B

Dividend Yield —

Revenue Growth 20.4% ↘

Op. Margin 37.1% ↗

ROIC 45.4% ↗

FCF / Share $1.01 ↗

Trailing P/E 7.4x

Price / Book 3.6x

FCF Yield 6.4%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$283.06M

↑ +20.4% —

Net Income Profit after all expenses

$287.20M

↑ +4893.1% —

Operating Margin Operating profit as % of sales

37.1%

↑ +1959.4% 92th

FCF / Share Free cash flow per share

$1.01

↑ +225.4% —

trending_up

Bullish Indicators

Operating Margin (%)Operating Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability

Returns

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 40-F ↗	FY 2016 Dec 31, 2016 40-F ↗
Revenue Growth YoY (%)	20.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+155%)	34.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+325%)	31.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+287%)	193.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2324%)	-9.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-213%)	15660.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+195655%)	-31.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-491%)	—	—	—
EPS Growth YoY (%)	5250.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	28.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	45.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-60.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	4893.1% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	27.9% Excellent ↑ Excellent Improving Year-over-year change in net income	40.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-76.2% Weak ↓ Weak Declining Year-over-year change in net income	-16.2% Weak ↑ Weak Improving Year-over-year change in net income	-66.5% Weak ↑ Weak Improving Year-over-year change in net income	25.0% Excellent Excellent Year-over-year change in net income	-203.9% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	225.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	N/M	58.3% Excellent Excellent Year-over-year change in free cash flow	54.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—
Revenue CAGR 3Y (%)	28.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	72.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	51.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	649.8% Excellent Excellent Compound annual revenue growth over 3 years	361.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	41.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	274.8% Excellent Excellent Compound annual revenue growth over 5 years	227.9% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 40-F ↗	FY 2016 Dec 31, 2016 40-F ↗
Operating Margin (%) (%)	37.1% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+147%)	-2.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-113%)	-52.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-448%)	-83.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-654%)	-396.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2742%)	-208.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1487%)	—	—	—	—
Effective Tax Rate (%) (%)	-151.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	22.8% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	—	2.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-80%)	-44.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-470%)	-80.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-773%)	-396.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3407%)	-204.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1807%)	—	—	—	—
FCF Margin (%) (%)	47.9% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	18.9% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	-19.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-59.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-345.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-139.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	7.72x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 40-F ↗	FY 2016 Dec 31, 2016 40-F ↗
Return on Invested Capital (%)	45.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-1.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-37.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-40.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	14.0% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-0.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-28.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	49.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+229%)	1.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-90%)	-20.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-238%)	-26.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-278%)	-37.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-352%)	-25.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-268%)	-29.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-297%)	-39.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-361%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 40-F ↗	FY 2016 Dec 31, 2016 40-F ↗
Interest Coverage (x)	—	—	-33.04x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	$-80.16M	$-83.40M	$-48.76M	$-94.09M	$-231.64M	$-272.35M	$-306.02M	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 40-F ↗	FY 2016 Dec 31, 2016 40-F ↗
Revenue per Share (USD)	$2.11	$1.64	$1.23	$0.94	$0.35	—	—	—	—	—
Basic EPS, GAAP (USD)	$2.14	$0.04	$-0.54	$-0.76	$-1.40	$-0.87	—	—	—	—
Free Cash Flow per Share (USD)	$1.01	$0.31	$-0.23	$-0.56	$-1.22	—	—	—	—	—
Book Value per Share (USD)	$4.39	$2.68	$2.63	$2.85	$3.38	$3.22	$2.67	$1.59	—	—
Tangible Book Value per Share (USD)	$4.39	$2.68	$2.63	$2.85	$3.38	$3.22	$2.67	$1.59	—	—
Basic Weighted Avg Shares (shares)	134.37M	143.06M	143.24M	141.91M	129.37M	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 40-F ↗	FY 2016 Dec 31, 2016 40-F ↗
Working Capital (USD)	$398.24M	$348.83M	$347.61M	$396.43M	$472.68M	$387.43M	$303.84M	—	—	—
Total Equity (USD)	$581.33M	$377.48M	$377.95M	$405.44M	$479.09M	$407.75M	$298.60M	$135.72M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 40-F ↗	FY 2016 Dec 31, 2016 40-F ↗
Sales/Revenue/Turnover (USD)	$283.06M	$235.13M	$175.51M	$134.03M	$45.60M	$50.12M	$318.00K	$463.00K	—	—
Depreciation Expense (USD)	$19.45M	$19.45M	$11.65M	$2.71M	$2.76M	$82.00K	$33.00K	$20.00K	—	—
Net Income, GAAP (USD)	$287.20M	$5.75M	$-78.02M	$-108.18M	$-180.97M	$-102.68M	$-88.39M	$-53.08M	$-70.79M	$-23.30M
Operating Cash Flow (USD)	$135.66M	$44.39M	$-33.46M	$-79.53M	$-157.69M	$-69.86M	$-63.59M	$-51.61M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 29 quarters

Aurinia Pharmaceuticals Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AUPH with peers